Kintor Pharmaceutical Limited (9939.HK)
HKD 1.31
(9.17%)
HKD 1.31
(9.17%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | - CNY | 0.0% |
| 2022 | - CNY | -100.0% |
| 2021 | 34.23 Thousand CNY | 0.0% |
| 2020 | - CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 698.00 CNY | -99.86% |
| 2017 | 489.92 Thousand CNY | -66.41% |
| 2016 | 1.45 Million CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q4 | - CNY | 0.0% |
| 2023 Q2 | - CNY | 0.0% |
| 2023 FY | - CNY | 0.0% |
| 2022 FY | - CNY | -100.0% |
| 2022 Q4 | - CNY | 0.0% |
| 2022 Q2 | - CNY | -100.0% |
| 2021 FY | 34.23 Thousand CNY | 0.0% |
| 2021 Q2 | - CNY | 0.0% |
| 2021 Q4 | 34.23 Thousand CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 FY | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 FY | - CNY | -100.0% |
| 2018 FY | 698.00 CNY | -99.86% |
| 2017 FY | 489.92 Thousand CNY | -66.41% |
| 2017 Q4 | 481.37 CNY | 5532.08% |
| 2017 Q2 | 8.55 CNY | -97.22% |
| 2016 Q4 | 307.55 CNY | -73.28% |
| 2016 Q2 | 1150.82 CNY | 0.0% |
| 2016 FY | 1.45 Million CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 484.71 Million HKD | 100.0% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.32 Billion HKD | 100.0% |